Business, energy, technology, markets and global industry news from Business News Today

donanemab

Medical Devices & Diagnostics

Grey Matters Health targets Alzheimer’s imaging bottleneck with dedicated PET clinic

Grey Matters Health’s planned NovaScan clinic in Florida will use the CareMiBrain dedicated PET system to expand access to amyloid imaging, while testing whether specialist neuroimaging can become a scalable outpatient service.

Read More
Pharma & Biotech

Elixiron’s oral Alzheimer’s drug data raise a bigger question: can neuroinflammation become the next serious treatment target?

Find out how Elixiron’s enrupatinib Phase 2 data could reshape Alzheimer’s neuroinflammation research and what risks remain.

Read More